期刊文献+

幽门螺杆菌的根治对肝硬化患者血氨的影响 被引量:2

Effects of the eradication of H pylori in patients with liver cirrhosis and hyperammonaemia
原文传递
导出
摘要 目的评价肝硬化患者Hp感染状况对血氨浓度的影响。方法对46例肝硬化伴高血氨患者的血液以及胃液中氨浓度进行分析,所有患者给予低蛋白饮食、卡那霉素、乳果糖以及丰富的支链氨基酸溶液治疗,其中24例患者仍有高血氨,根据Hp感染分布的状况,把24例患者分成三组:Hp在胃中弥漫性分布的患者为Ⅰ组,Hp在胃中局部分布的患者为Ⅱ组,Hp阴性的患者为Ⅲ组。24例患者均给予口服10 mg雷贝拉唑,1000 mg阿莫西林以及400 mg克拉霉素或500 mg甲硝唑2周进行Hp的根治。结果第Ⅰ组Hp根治后血液以及胃液中血氨浓度明显下降,Hp根治12周后血氨浓度明显降低(P<0.05),第Ⅱ组、Ⅲ组进行Hp根治后血氨浓度未见明显降低。结论胃中Hp弥漫性感染是导致肝硬化患者血氨升高的原因之一,针对Hp弥漫性分布的肝硬化患者,必须进行有效的Hp根治。 Objective This study aimed to evaluate whether ammonia levels were influenced by H pylori status in a series of 46 cirrhotic patients. Methods Ammonia concentrations in blood and gastric juice were analysed in 46 patients with liver cirrhosis and hyperammonaemia. All patients were first treated with a low protein diet, kanamycin, lactulose, and branched chain enriched amino acid solution. Hyperammonaemia remained in 24 patients. These 24 patients were divided into three groups according to the status of H pylori infection, those with a diffuse distribution of H pylori in the stomach (group Ⅰ), those with a regional distribution (group Ⅱ), and those without H pylori (group Ⅲ). These patients were given 10 mg rabeprazole, 1000 mg amoxicillin, and 400 mg clarithromyc in or 500 mg metronidazole for two weeks to eradicate H pylori. Results In group Ⅰ ammonia concentrations in blood and gastric juice were significantly reduced after H pylori eradication( P 〈 0.05 ). The blood ammonia concentration at 12 weeks after the eradication was still significantly lower than that before eradication. In groups Ⅱ and Ⅲ the ammonia concentrations in blood and gastric juice were not significantly reduced after eradication therapy. Conclusion The diffuse distribution of H - pylori in the stomach contributes partly to hyperammonaemia in patients with liver cirrhosis, and the e- radication of H pylori is effective in patients with hyperammonaemia with diffuse H pylori infection in the stomach.
出处 《临床医学》 CAS 2007年第3期91-92,共2页 Clinical Medicine
关键词 幽门螺杆菌 高血氨 肝硬化 尿素酶 Helicobacter pylori Hyperammonaemia Liver cirrhosis Urease
  • 相关文献

参考文献10

  • 1The Eurogast Study Group.Epidemiology of,and risk factors for,Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations[J].Gut,1994,34:1672-1676.
  • 2Dunn BE,Campbell GP,Perez-Perez GI,et al.Purification and characterization of urease fron Helicobacter pylori[J].J Biol Chem,1990,265(16):9464-9469.
  • 3Ito S,Kohli Y,Kato T,et al.Significance of ammonia produced by Helicobater pylori[J].Eur J Gastroenterol Hepatol,1994,6:167-174.
  • 4厉有名,伊藤重二,郡大裕,石井靖,黄怀德.幽门螺杆菌诱发肝硬化大鼠高氨血症的实验研究[J].中华内科杂志,1997,36(2):125-126. 被引量:44
  • 5Miyaji H,Ito S,Azuma T,et al.Effects of Helicobacter pylori eradication therapy on hyperammonaemia in patients with liver cirrhosis[J].Gut,1997,40:726-730.
  • 6Higuchi K,Shimizu Y,Nambu S,et al.Effects of an infusion of branched-chain amino acids on neurophysiological and psychometric testings in cirrhotic patients with mild hepatic encephalopathy[J].J Gastroenterol Hepatol,1994,9:366-372.
  • 7Diehl AM.Acute and chronic hepatic failure and hepatic encephalopa-thy[M]//Goldman L,Bennett JC.Cecil textbook of medicine.21th ed.P hiladelphia:Saunders Company,2000:813-816.
  • 8张大真,李增烈.幽门螺杆菌感染与肝硬化高氨血症的关系[J].中华消化杂志,2000,20(6):397-398. 被引量:23
  • 9Quero JC,Hartmann IJ,De Rooij F,et al.Hyperammonaemia and Helicobacter pylori[J].Lancet,1995,346:713-714.
  • 10Plevris JN,Morgenstern R,Hayes PC,et al.Hyperammonaemia in cirrhosis and Helicobacter pylori infection[J].Lancet,1995,346:1104.

二级参考文献2

共引文献64

同被引文献8

  • 1高鲁宁.肝硬化患者合并幽门螺杆菌感染与高氨血症的关系[J].中原医刊,2004,31(16):2-3. 被引量:1
  • 2刘建生,田怡,付极,张晓红,刘进,林健.益生菌治疗亚临床肝性脑病对其转归的影响及机制[J].中国医师进修杂志,2006,29(1):12-14. 被引量:7
  • 3Dasani BM, Sigal SH, Lieber CS. Analysis of risk factors for chronic hepatic encephalopathy: the role of Helicobacter pylori infection. Am J Gastroenterol, 1998,93 ( 5 ) : 726-731.
  • 4Miquel J, Barcena R, Boixeda D, et al. Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy. Eur J Gastroenterol Hepatol,2001,13 (9) : 1067- 1072.
  • 5Miyaji H, ho S, Azuma T, et al. Effects of Helicobacter pylori eradication therapy on hyperammon aemia in patients with liver cirrhosis. Gut, 1997,40(6) :726-730.
  • 6Higuchi K, Shimizu Y, Nambu S, et al. Effects of an infusion of branched-chain amion acids on neurophysiological and psychometric testings in cirrhotic patients with mild hepatic encephalnpathy. J Gastroenteml Hepatol, 1994,9:366-372.
  • 7Miyahi H, ho S, Azuma T, et al. Effects of helicobacter pylori eradication therapy on hyperammonnaemia in patients with liver eirrhosis. Gut, 1997,40:726-730.
  • 8中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14009

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部